University of Cincinnati Start-up Company Opportunities - - PowerPoint PPT Presentation

university of cincinnati start up company opportunities
SMART_READER_LITE
LIVE PREVIEW

University of Cincinnati Start-up Company Opportunities - - PowerPoint PPT Presentation

University of Cincinnati Start-up Company Opportunities NCET2/Global 1000 Conference March 19, 2014 Dorothy H. Air, PhD Associate Vice President Entrepreneurial Affairs & Tech Commercialization dorothy.air@uc.edu University of Cincinnati


slide-1
SLIDE 1

University of Cincinnati Start-up Company Opportunities

NCET2/Global 1000 Conference March 19, 2014

Dorothy H. Air, PhD Associate Vice President Entrepreneurial Affairs & Tech Commercialization dorothy.air@uc.edu

slide-2
SLIDE 2

University of Cincinnati Technology Commercialization

  • Technology Commercialization Accelerator

– Newly launched one-stop resource for translating scientific breakthroughs into market opportunities – Provides:

  • Commercialization Gap Funding
  • Entrepreneurs-in-residence to evaluate and guide

commercialization work

  • External Advisory Board to assist in opportunity

assessment and connections to external resources

  • Intellectual Property functions aligned with

commercialization potential

slide-3
SLIDE 3

Opportunity Base

Research Intensive University $227 Million Research Expenditures

2010 2011 2012 2013 Invention Disclosures 82 106 123 98 Patent Applications 50 70 75 95 Patents Issued 16 11 20 17 Start-up Activity 7 3 6 2

slide-4
SLIDE 4

Research and Innovation Strengths

Partial list . . .

  • Nanotechnology
  • Sensors and Controls
  • Intelligent Autonomous

Systems

  • Sustainable Urban

Engineering

  • Robotics
  • Microfluidics
  • Microfilms
  • BioMEMS
  • Semi Conductors
  • Energy Systems
  • Power & Propulsion
  • Industrial Design
  • Water Quality Biotechnology
  • Cybersecurity
  • Imaging
  • Tissue Engineering
  • Medical Devices
  • Diagnostics and Therapeutics
  • Cancer Biology
  • Cardiovascular and Pulmonary

Biology

  • Immunobiology
  • Neuroscience
  • Molecular Genetics
  • Environmental Health
  • Gastrointestinal Biology
slide-5
SLIDE 5

SENSE Diagnostics, LLC

  • Company Summary:

– Early stage start-up neurotechnology company developing a medical device for Sensor Evaluation of Neurologic Status in Emergencies (SENSE) in response to a large unmet market need.

  • Product:

– A non-invasive radio frequency based device that detects sudden signal changes in brain status in seizures, hemorrhage, or increased brain swelling.

  • Competitive Advantages:

– 1st non-invasive, continuous device monitor – Portability for use in field, OR, ED, patient room – Low cost and greater effectiveness than CT, EEG, BIS and MEG – Potential major health care savings through

  • Immediate change identification to mitigate disabling patient outcomes
  • Ease of use (no reliance on correct wire lead placement, ionizing

radiation or highly-trained experts)

  • IP: pending US and EP applications
  • Funding Status: $170,000 University and NIH NIBIB Grants;

Raising 1st capital round

slide-6
SLIDE 6

Gamma Dynamics

  • Company Summary:

– Early stage start-up company focused on electrofluidics-based display products, with 4 platforms demonstrated and under development

  • Product:

– Electrofluidic display technology for various e-Paper applications such as

eBook readers. Also applications for store product labels and signs

  • Competitive Advantages

– High brightness and optimal readability in direct sunlight. – Flexible, even rollable/foldable displays allowing large i-Pad type screen sizes to be stored with the pocket size of a smart phone. – Full color and video capabiklity. Since the displays – No backlighting with extremely low – no heavy batteries

  • Patent Status: 3 pending & 3 issued US patents, 2 allowed US applications
  • Funding: $3,043,165 federal & $043,165 non-federal funding;

raising A round

slide-7
SLIDE 7

Eccrine Systems, LLC

  • Company Summary:

– Early stage start-up focused on technology for real-time capture and analysis of eccrine sweat via wearable sweat sensor – Strategic “vertical” business model for maximum horizontal positioning across markets with vertical segment preservation for maximum economic potential.

  • Product: Wearable microfluidics and flexible electronics sensor that

enables the real-time capture, sensing, measurement, and wireless communication of biomolecules to smart phones and other reporting devices for monitoring status of multiple physical conditions.

  • Competitive Advantages:

– Novel approach for measuring biomolecules – Applicable to 3 huge markets: elite performers, medical diagnostics, consumer lifestyle management. (Potential $2B global market) – Proof of concept, 4 platforms demonstrated, and prototype established – Low manufacturing Cost

  • IP: pending provisional and PCT applications
  • Funding Status: $850,000 in non-dilutive funding; Raising Seed-Round
slide-8
SLIDE 8

OsteoDynamics, Inc.

  • Company Summary:

– Start-up company developing diagnostic device that measures bone quality enabling better identification of patients at risk for osteoporosis- related fractures than is possible through bone mineral density measures. Prototype and clinical validation data completed.

  • Product:

– A device and related software to measure Bone Shock Absorption energy in mild shock waves from normal activities (walking, foot tapping)

  • Competitive Advantages:

– Significant health care savings through more effective determination of and treatment recommendations for osteoporosis related bone fractures – Low cost technology and easy patient access – Portability and ability to use in standard patient examining room

  • Patent Status: pending US application
  • Funding: $160,000 grant awards; $286,050 founders and

convertible notes; Raising $1.4M to take through FDA approval

slide-9
SLIDE 9

Contact OEATC

Web Address: http://ipo.uc.edu Available Techs: http://ipo.uc.edu/tech Twitter: http://twitter.com/oeatc Phone: (513) 558-6293

Dorothy H. Air, PhD Associate Vice President, Entrepreneurial Affairs and Technology Commercialization dorothy.air@uc.edu